Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients aged 10 years and above with up to 55 decibels sensorineural hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
The Cochlear Osia 2 Sound Processor is compatible with Apple devices. The Osia Smart App is available on App Store and Google Play. For compatibility information, visit www.cochlear.com/compatibility.
Apple, the Apple logo, Apple Watch, FaceTime, Made for iPad logo, Made for iPhone logo, Made for iPod logo, iPhone, iPad Pro, iPad Air, iPad mini, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc., registered in the U.S. and other countries.
Android is a trademark of Google LLC. The Android robot is reproduced or modified from work created and shared by Google and used according to terms described in the Creative Commons 3.0 Attribution License. Google Play and the Google Play logo are trademarks of Google LLC.